BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29089756)

  • 1. Computerized screening for cognitive impairment in patients with COPD.
    Campman C; van Ranst D; Meijer JW; Sitskoorn M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3075-3083. PubMed ID: 29089756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of a Computerized Cognitive Battery in Children and Adolescents with Neurological Diagnoses.
    Plourde V; Hrabok M; Sherman EMS; Brooks BL
    Arch Clin Neuropsychol; 2018 Mar; 33(2):247-253. PubMed ID: 28981565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-specific cognitive impairment in patients with COPD and control subjects.
    Cleutjens FA; Franssen FM; Spruit MA; Vanfleteren LE; Gijsen C; Dijkstra JB; Ponds RW; Wouters EF; Janssen DJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1-11. PubMed ID: 28031706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing.
    Brooks BL; Iverson GL; Sherman EM; Roberge MC
    Appl Neuropsychol; 2010 Jan; 17(1):37-43. PubMed ID: 20146120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.
    Gualtieri CT; Johnson LG
    Arch Clin Neuropsychol; 2006 Oct; 21(7):623-43. PubMed ID: 17014981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized neuropsychological testing to rapidly evaluate cognition in pediatric patients with neurologic disorders.
    Brooks BL; Sherman EM
    J Child Neurol; 2012 Aug; 27(8):982-91. PubMed ID: 22290863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Computerized Cognitive Testing Useful in Children and Adolescents with Moderate-to-Severe Traumatic Brain Injury?
    Plourde V; Brooks BL
    J Int Neuropsychol Soc; 2017 Apr; 23(4):304-313. PubMed ID: 28215191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure of the CNS Vital Signs computerized cognitive battery in youth with neurological diagnoses.
    Brooks BL; Plourde V; Fay-McClymont TB; MacAllister WS; Sherman EMS
    Child Neuropsychol; 2019 Oct; 25(7):980-991. PubMed ID: 30676266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computerized test battery sensitive to mild and severe brain injury.
    Gualtieri CT; Johnson LG
    Medscape J Med; 2008 Apr; 10(4):90. PubMed ID: 18504479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized cognitive testing in epilepsy (CCTE): a new method for cognitive screening.
    Kurzbuch K; Pauli E; Gaál L; Kerling F; Kasper BS; Stefan H; Hamer H; Graf W
    Seizure; 2013 Jul; 22(6):424-32. PubMed ID: 22999215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for neuropsychological impairment in COPD patients undergoing rehabilitation.
    Pierobon A; Ranzini L; Torlaschi V; Sini Bottelli E; Giardini A; Bruschi C; Maestri R; Callegari S; Raccanelli R; Sommaruga M
    PLoS One; 2018; 13(8):e0199736. PubMed ID: 30067787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the default mode network and cognitive impairments in patients with chronic obstructive pulmonary disease.
    Hu X; Wang H; Tu Y; Fei M; Yin M; Fei G; Yu Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():519-528. PubMed ID: 29445270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and cognitive disorders of postmenopausal women measured by a battery of computer tests--central nervous system vital signs.
    Raszewski G; Loroch M; Owoc A; Łukawski K; Filip R; Bojar I
    Arch Womens Ment Health; 2015 Aug; 18(4):623-30. PubMed ID: 25822709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function and its relationship to other psychosocial factors in lymphoma survivors.
    Krolak D; Collins B; Weiss L; Harris C; Van der Jagt R
    Support Care Cancer; 2017 Mar; 25(3):905-913. PubMed ID: 27837322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Neurocognitive Functions in Children and Adolescents with Obesity.
    Bozkurt H; Özer S; Yılmaz R; Sönmezgöz E; Kazancı Ö; Erbaş O; Demir O
    Appl Neuropsychol Child; 2017; 6(4):262-268. PubMed ID: 27183151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
    Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in COPD: a systematic review.
    Torres-Sánchez I; Rodríguez-Alzueta E; Cabrera-Martos I; López-Torres I; Moreno-Ramírez MP; Valenza MC
    J Bras Pneumol; 2015; 41(2):182-90. PubMed ID: 25909154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.